WHO Guidelines on Hand Hygiene in Health Care - Safe Care ...

REFERENCES
400. McMurry LM, McDermott PF, Levy SB. Genetic evidence
that InhA of Mycobacterium smegmatis is a target for
triclosan. Antimicrobial Agents and Chemotherapy, 1999,
43:711–713.
401. Weber DJ, Rutala WA. Use of germicides in the home and
the healthcare setting: is there a relationship between
germicide use and antibiotic resistance? Infection Control
and Hospital Epidemiology, 2006, 27:1107–1119.
402. Maillard JY. Bacterial resistance to biocides in the
healthcare environment: should it be of genuine concern?
Journal of Hospital Infection, 2007, 65(Suppl. 2):60–72.
403. Lowbury EJL, Lilly HA, Bull JP. Disinfection of hands:
removal of transient organisms. BMJ, 1964, 2:230–233.
404. Rotter ML. Semmelweis’ sesquicentennial: a little-noted
anniversary of handwashing. Current Opinion in Infectious
Diseases, 1998, 11:457–460.
405. Kampf G et al. Dermal tolerance and effect on skin hydration
of a new ethanol-based hand gel. Journal of Hospital
Infection, 2002, 52:297–301.
406. Manivannan G et al. Immediate, persistent and residual
antimicrobial efficiency of surfacine hand sanitizer. Infection
Control and Hospital Epidemiology, 2000, 21:105.
407. Nhung DT et al. Sustained antibacterial effect of a hand
rub gel incorporating chlorhexidine-loaded nanocapsules
(Nanochlorex). International Journal of Pharmacy, 2007,
334:166–172.
408. Kuijper EJ, Coignard B, Tull P. Emergence of Clostridium
difficile-associated disease in North America and Europe.
Clinical Microbiology and Infection, 2006, 12(Suppl. 6):2–18.
409. Loo VG et al. A predominantly clonal multi-institutional
outbreak of Clostridium difficile-associated diarrhea with
high morbidity and mortality. New England Journal of
Medicine, 2005, 353:2442–2449.
410. McDonald LC et al. An epidemic, toxin gene-variant strain
of Clostridium difficile. New England Journal of Medicine,
2005, 353:2433–2441.
411. Hubert B et al. A portrait of the geographic dissemination
of the Clostridium difficile North American pulsed-field type
1 strain and the epidemiology of C. difficile-associated
disease in Quebec. Clinical Infectious Diseases, 2007,
44:238–244.
412. Joseph R et al. First isolation of Clostridium difficile PCR
ribotype 027, toxinotype III in Belgium. Eurosurveillance,
2005, 10:E051020 4.
413. Smith A. Outbreak of Clostridium difficile infection in an
English hospital linked to hypertoxin-producing strains in
Canada and the US. Eurosurveillance, 2005, 10:E050630 2.
414. Coignard B et al. Emergence of Clostridium difficile
toxinotype III, PCR-ribotype 027-associated disease,
France, 2006. Eurosurveillance, 2006, 11:E060914 1.
415. Kuijper EJ et al. Clostridium difficile ribotype 027, toxinotype
III, the Netherlands. Emerging Infectious Diseases, 2006,
12:827–830.
416. Delmee M et al. Epidemiology of Clostridium difficile
toxinotype III, PCR-ribotype 027 associated disease in
Belgium, 2006. Eurosurveillance, 2006, 11:E060914 2.
417. Brazier JS, Patel B, Pearson A. Distribution of
Clostridium difficile PCR ribotype 027 in British hospitals.
Eurosurveillance, 2007, 12:E070426 2.
418. Gershenfeld L. Povidone-iodine as a sporicide. American
Journal of Pharmacy, 1962, 134:79–81.
419. Russell AD. Chemical sporicidal and sporostatic agents. In:
Block SS, ed. Disinfection, sterilization and preservation, 4th
ed. Philadelphia, PA, Lea & Febiger, 1991:365–376.
420. Bettin K et al. Effectiveness of liquid soap vs chlorhexidine
gluconate for the removal of Clostridium difficile from bare
hands and gloved hands. Infection Control and Hospital
Epidemiology, 1994, 15:697–702.
421. Hubner NO et al. Effect of a 1 min hand wash on the
bactericidal efficacy of consecutive surgical hand
disinfection with standard alcohols and on skin hydration.
International Journal of Hygiene and Environmental Health,
2006, 209:285–291.
422. Johnson S et al. Prospective, controlled study of vinyl
glove use to interrupt Clostridium difficile nosocomial
transmission. American Journal of Medicine, 1990,
88:137–140.
423. Guideline for isolation precautions: preventing transmission
of infectious agents in healthcare settings. Atlanta, GA,
Centers for Disease Control and Prevention, 2007.
424. Clabots CR et al. Detection of asymptomatic Clostridium
difficile carriage by an alcohol shock procedure. Journal of
Clinical Microbiology, 1989, 27:2386–2387.
425. Wullt M, Odenholt I, Walder M. Activity of three disinfectants
and acidified nitrite against Clostridium difficile spores.
Infection Control and Hospital Epidemiology, 2003,
24:765–768.
426. Boyce JM et al. Lack of association between the increased
incidence of Clostridium difficile-associated disease and the
increasing use of alcohol-based hand rubs. Infection Control
and Hospital Epidemiology, 2006, 27:479–483.
427. Muto CA et al. A large outbreak of Clostridium difficileassociated
disease with an unexpected proportion of deaths
and colectomies at a teaching hospital following increased
fluoroquinolone use. Infection Control and Hospital
Epidemiology, 2005, 26:273–280.
428. Gordin FM et al. Reduction in nosocomial transmission
of drug-resistant bacteria after introduction of an
alcohol-based handrub. Infection Control and Hospital
Epidemiology, 2005, 26:650–653.
429. Gopal Rao G et al. Marketing hand hygiene in hospitals – a
case study. Journal of Hospital Infection, 2002, 50:42–47.
430. McDonald LC, Owings M, Jernigan DB. Clostridium
difficile infection in patients discharged from US short-stay
hospitals, 1996–2003. Emerging Infectious Diseases, 2006,
12:409–415.
431. Archibald LK, Banerjee SN, Jarvis WR. Secular trends in
hospital-acquired Clostridium difficile disease in the United
States, 1987–2001. Journal of Infectious Diseases, 2004,
189:1585–1589.
432. Weber DJ et al. Efficacy of selected hand hygiene agents
used to remove Bacillus atrophaeus (a surrogate of
Bacillus anthracis) from contaminated hands. JAMA, 2003,
289:1274–1277.
433. Russell AD. Mechanisms of bacterial insusceptibility to
biocides. American Journal of Infection Control, 2001,
29:259–261.
434. Cookson BD, Bolton MC, Platt JH. Chlorhexidine resistance
in methicillin-resistant Staphylococcus aureus or just
an elevated MIC? An in vitro and in vivo assessment.
Antimicrobial Agents and Chemotherapy, 1991,
35:1997–2002.
217